A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.
The ability of a series of polysulphonated naphthylureas structurally related to suramin to inhibit basic fibroblast growth factor (bFGF) or serum-stimulated growth of endothelial cells [either large vessel, human umbilical vein endothelial cells (HUVEC) or microvascular, bovine adrenal capillary en...
Main Authors: | Braddock, P. S., Hu, D. E., Fan, T. P., Stratford, I. J., Harris, A. L., Bicknell, R. |
---|---|
Format: | Online |
Language: | English |
Published: |
1994
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968907/ |
Similar Items
-
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
by: Pesenti, E., et al.
Published: (1992) -
Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.
by: Bernardini, N., et al.
Published: (1993) -
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
by: Dirix, L. Y., et al.
Published: (1997) -
Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.
by: Leith, J. T., et al.
Published: (1992) -
Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin
Published: (1989)